BDNF and atypical Rett syndrome: Moreover, administration of fingolimod, a sphingosine-1 phosphate analogue, effectively increases BDNF levels by inducing the activation of the TrkB-MAPK-CREB pathway in a mouse model of Rett syndrome [4].